AstraZeneca Pharma India Statistics

Total Valuation

BOM:506820 has a market cap or net worth of INR 207.28 billion. The enterprise value is 202.27 billion.

Market Cap	207.28B
Enterprise Value	202.27B

Important Dates

The last earnings date was Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	Jul 18, 2025

Share Statistics

BOM:506820 has 25.00 million shares outstanding. The number of shares has increased by 0.05% in one year.

Current Share Class	25.00M
Shares Outstanding	25.00M
Shares Change (YoY)	+0.05%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	8.02%
Owned by Institutions (%)	7.18%
Float	4.14M

Valuation Ratios

The trailing PE ratio is 113.07.

PE Ratio	113.07
Forward PE	n/a
PS Ratio	11.16
PB Ratio	26.91
P/TBV Ratio	26.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	110.31
EV / Sales	10.89
EV / EBITDA	69.65
EV / EBIT	80.49
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.05
Debt / EBITDA	0.12
Debt / FCF	n/a
Interest Coverage	121.41

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	20.63%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	23.17M
Profits Per Employee	2.29M
Employee Count	802
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BOM:506820 has paid 628.60 million in taxes.

Income Tax	628.60M
Effective Tax Rate	25.53%

Stock Price Statistics

The stock price has increased by +25.50% in the last 52 weeks. The beta is 0.13, so BOM:506820's price volatility has been lower than the market average.

Beta (5Y)	0.13
52-Week Price Change	+25.50%
50-Day Moving Average	9,170.54
200-Day Moving Average	7,917.51
Relative Strength Index (RSI)	31.52
Average Volume (20 Days)	1,418

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:506820 had revenue of INR 18.58 billion and earned 1.83 billion in profits. Earnings per share was 73.33.

Revenue	18.58B
Gross Profit	8.24B
Operating Income	2.51B
Pretax Income	2.46B
Net Income	1.83B
EBITDA	2.90B
EBIT	2.51B
Earnings Per Share (EPS)	73.33

Full Income Statement

Balance Sheet

The company has 5.36 billion in cash and 357.30 million in debt, giving a net cash position of 5.00 billion or 200.16 per share.

Cash & Cash Equivalents	5.36B
Total Debt	357.30M
Net Cash	5.00B
Net Cash Per Share	200.16
Equity (Book Value)	7.70B
Book Value Per Share	308.14
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 44.36%, with operating and profit margins of 13.53% and 9.87%.

Gross Margin	44.36%
Operating Margin	13.53%
Pretax Margin	13.25%
Profit Margin	9.87%
EBITDA Margin	15.63%
EBIT Margin	13.53%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 32.00, which amounts to a dividend yield of 0.39%.

Dividend Per Share	32.00
Dividend Yield	0.39%
Dividend Growth (YoY)	33.33%
Years of Dividend Growth	3
Payout Ratio	n/a
Buyback Yield	-0.05%
Shareholder Yield	0.33%
Earnings Yield	0.88%
FCF Yield	n/a

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 15, 2006. It was a forward split with a ratio of 5.

Last Split Date	Jun 15, 2006
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	1